Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 8
2021 28
2022 23
2023 14
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects.
Paul S, Chakraborty S, Anand U, Dey S, Nandy S, Ghorai M, Saha SC, Patil MT, Kandimalla R, Proćków J, Dey A. Paul S, et al. Biomed Pharmacother. 2021 Nov;143:112175. doi: 10.1016/j.biopha.2021.112175. Epub 2021 Sep 27. Biomed Pharmacother. 2021. PMID: 34649336 Free article. Review.
Withania somnifera (L.) Dunal (Solanaceae) has been used as a traditional Rasayana herb for a long time. ...
Withania somnifera (L.) Dunal (Solanaceae) has been used as a traditional Rasayana herb for a long time. ...
Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management.
Saggam A, Limgaokar K, Borse S, Chavan-Gautam P, Dixit S, Tillu G, Patwardhan B. Saggam A, et al. Front Pharmacol. 2021 May 3;12:623795. doi: 10.3389/fphar.2021.623795. eCollection 2021. Front Pharmacol. 2021. PMID: 34012390 Free PMC article. Review.
Ayurvedic medicines, especially Ashwagandha (Withania somnifera (L.) Dunal, WS), may be beneficial in the management of COVID-19. ...The review proposes WS as a potential therapeutic adjuvant for various stages of COVID-19 management. WS may als …
Ayurvedic medicines, especially Ashwagandha (Withania somnifera (L.) Dunal, WS), may be beneficial in the management of COVID- …
Interventions for generalized anxiety disorder.
Byrne GJ. Byrne GJ. Curr Opin Psychiatry. 2023 Mar 1;36(2):134-139. doi: 10.1097/YCO.0000000000000840. Epub 2022 Dec 6. Curr Opin Psychiatry. 2023. PMID: 36705012
RECENT FINDINGS: Self-reported anxiety symptoms were highly prevalent during the COVID-19 global pandemic in both the general population and in selected groups. ...There was some evidence of efficacy for complementary therapies, including physical exercise, yoga, ac …
RECENT FINDINGS: Self-reported anxiety symptoms were highly prevalent during the COVID-19 global pandemic in both the general …
Ashwagandha (Withania somnifera) and Shunthi (Zingiber officinale) in mild and moderate COVID-19: An open-label randomized controlled exploratory trial.
Singh H, Yadav B, Rai AK, Srivastava S, Saiprasad A, Jameela S, Singhal R, Muralidharan S, Mohan R, Chaudhary S, Rana R, Khanduri S, Sharma BS, Chandrasekhararao B, Srikanth N, Dhiman KS. Singh H, et al. Complement Ther Med. 2023 Sep;76:102966. doi: 10.1016/j.ctim.2023.102966. Epub 2023 Jul 22. Complement Ther Med. 2023. PMID: 37482107 Free article. Clinical Trial.
BACKGROUND: Ayurveda interventions have been used for prophylaxis and care during the COVID-19 pandemic in India and have shown promising results in promoting early clinical recovery from COVID-19. ...METHODS: A randomized controlled exploratory trial …
BACKGROUND: Ayurveda interventions have been used for prophylaxis and care during the COVID-19 pandemic in India and have show …
Withanolides from Withania somnifera as an immunity booster and their therapeutic options against COVID-19.
Khanal P, Chikhale R, Dey YN, Pasha I, Chand S, Gurav N, Ayyanar M, Patil BM, Gurav S. Khanal P, et al. J Biomol Struct Dyn. 2022 Aug;40(12):5295-5308. doi: 10.1080/07391102.2020.1869588. Epub 2021 Jan 18. J Biomol Struct Dyn. 2022. PMID: 33459174
Traditionally, Withania somnifera is widely used as an immune booster, anti-viral, and for multiple medicinal purposes. ...Among multiple withanolides from W. somnifera, Withanolide_D, Withanolide_G, Withanolide_M, and Withanolide_Q were predicted as the lead hits based on …
Traditionally, Withania somnifera is widely used as an immune booster, anti-viral, and for multiple medicinal purposes. ...Among mult …
Analysis of medicinal and therapeutic potential of Withania somnifera derivatives against COVID-19.
Gheshlaghi SZ, Nakhaei E, Ebrahimi A, Jafari M, Shahraki A, Rezazadeh S, Saberinasab E, Nowroozi A, Hosseini SS. Gheshlaghi SZ, et al. J Biomol Struct Dyn. 2023 Aug-Sep;41(14):6883-6893. doi: 10.1080/07391102.2022.2112977. Epub 2022 Aug 22. J Biomol Struct Dyn. 2023. PMID: 35993530
Apart from chemical and allopathic drugs, several medicinal plants contain phytochemicals that are potentially useful to counter the COVID-19 pandemic. Withania somnifera (Ashwagandha), which has a good effect on some viral infections, can be considered as a …
Apart from chemical and allopathic drugs, several medicinal plants contain phytochemicals that are potentially useful to counter the COVI
Withania somnifera as a safer option to hydroxychloroquine in the chemoprophylaxis of COVID-19: Results of interim analysis.
Chopra A, Srikanth N, Patwardhan B; AYUSH CCRAS Research Group. Chopra A, et al. Complement Ther Med. 2021 Nov;62:102768. doi: 10.1016/j.ctim.2021.102768. Epub 2021 Aug 18. Complement Ther Med. 2021. PMID: 34418550 Free PMC article. Clinical Trial.
OBJECTIVES: To study the efficacy and safety of Withania somnifera (WS, Ashwagandha) in the prophylaxis against COVID-19 in high risk health care workers (HCW) in comparison to hydroxychloroquine (HCQ). ...The primary efficacy measure was 'failure of prophyla …
OBJECTIVES: To study the efficacy and safety of Withania somnifera (WS, Ashwagandha) in the prophylaxis against COVID-19
COVID-19: General Strategies for Herbal Therapies.
Soleymani S, Naghizadeh A, Karimi M, Zarei A, Mardi R, Kordafshari G, Esmaealzadeh N, Zargaran A. Soleymani S, et al. J Evid Based Integr Med. 2022 Jan-Dec;27:2515690X211053641. doi: 10.1177/2515690X211053641. J Evid Based Integr Med. 2022. PMID: 34985368 Free PMC article.
The coronavirus disease-2019 (COVID-19) pandemic started in early 2020 with the outbreak of a highly pathogenic human coronavirus. ...Considering the potential of natural products to manage the pandemic, this article was designed to provide an inclusive map of the s …
The coronavirus disease-2019 (COVID-19) pandemic started in early 2020 with the outbreak of a highly pathogenic human coronavi …
Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants - Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi) - a molecular docking study.
Shree P, Mishra P, Selvaraj C, Singh SK, Chaube R, Garg N, Tripathi YB. Shree P, et al. J Biomol Struct Dyn. 2022 Jan;40(1):190-203. doi: 10.1080/07391102.2020.1810778. Epub 2020 Aug 27. J Biomol Struct Dyn. 2022. PMID: 32851919 Free PMC article.
COVID-19 (Coronavirus disease 2019) is a transmissible disease initiated and propagated through a new virus strain SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) since 31(st) December 2019 in Wuhan city of China and the infection h
COVID-19 (Coronavirus disease 2019) is a transmissible disease initiated and propagated through a new virus strain SARS
63 results